DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on March 9, 2009; DOI: 10.1124/dmd.109.026591


0090-9556/09/3706-1334-1337$20.00
DMD 37:1334-1337, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.109.026591v1
37/6/1334    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mols, R.
Right arrow Articles by Augustijns, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mols, R.
Right arrow Articles by Augustijns, P.
ACCELERATED COMMUNICATION

INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE

Evaluation of a Novel Tool in Biopharmaceutical Drug Profiling

Raf Mols1, Joachim Brouwers1, Alfred H. Schinkel, Pieter Annaert, and Patrick Augustijns

Laboratory for Pharmacotechnology and Biopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium (R.M., J.B., P.An., P.Au.); and Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands (A.H.S.)

Abstract

In the present study, we successfully downscaled, for the first time, the in situ intestinal perfusion technique with mesenteric blood sampling from rat to mouse. To evaluate the feasibility of this approach, we assessed the apparent permeability (Papp) of mouse intestine for a set of marker compounds [atenolol, paracellular transport; metoprolol, transcellular transport; talinolol, P-glycoprotein (P-gp)-mediated efflux] in both wild-type and P-gp-deficient mice. In wild-type mice, the observed Papp values for atenolol (1.8 ± 0.3 x 10–6 cm/s) and metoprolol (50.2 ± 20.1 x 10–6 cm/s) were not significantly affected by inclusion of the P-gp inhibitor verapamil. In contrast, the Papp value for talinolol (0.9 ± 0.3 x 10–6 cm/s) increased 5-fold in the presence of verapamil. The similarity between these values and previously determined Papp values in rats indicates comparable passive barrier functions and P-gp-mediated efflux transport between mice and rats. In comparison with wild-type mice, the apparent permeability in P-gp-deficient mdr1a/1b(–/–) mice was significantly altered for talinolol (7-fold increase) but not for atenolol or metoprolol. Because of the availability of knockout mice, the intestinal perfusion technique with mesenteric blood sampling in mice may become an important tool to elucidate the role of intestinal metabolism and active transport in drug absorption during preclinical drug evaluation.


Address correspondence to: Patrick Augustijns, Laboratory for Pharmacotechnology and Biopharmacy, K.U.Leuven, Gasthuisberg ON 2, Herestraat 49 Box 921, BE-3000 Leuven, Belgium. E-mail: patrick.augustijns{at}pharm.kuleuven.be







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.